These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 19509501)

  • 61. Udenafil, a long-acting PDE5 inhibitor for erectile dysfunction.
    Salem EA; Kendirci M; Hellstrom WJ
    Curr Opin Investig Drugs; 2006 Jul; 7(7):661-9. PubMed ID: 16869121
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Therapeutic strategies for managing erectile dysfunction: a step-care approach.
    Carson CC
    J Am Osteopath Assoc; 2002 Dec; 102(12 Suppl 4):S12-8. PubMed ID: 12572636
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Prevention and treatment of erectile dysfunction during peri-operation period of radical retropubic prostatectomy].
    Ying J; Yao DH
    Zhonghua Nan Ke Xue; 2006 Jan; 12(1):89-92. PubMed ID: 16483171
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Management of erectile dysfunction after radical prostatectomy in 2007.
    Briganti A; Salonia A; Gallina A; Chun FK; Karakiewicz PI; Graefen M; Huland H; Rigatti P; Montorsi F
    World J Urol; 2007 Apr; 25(2):143-8. PubMed ID: 17340159
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Sex or surgery--erectile dysfunction after radical treatment of localized prostate cancer.
    Kelović VL; Buković D; Badzek S; Curić Z; Kelović Z; Persec Z; Pavić M
    Coll Antropol; 2009 Jun; 33(2):529-32. PubMed ID: 19662774
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Emergency department considerations regarding erectile dysfunction.
    Hollander JE
    Am J Cardiol; 2005 Dec; 96(12B):73M-75M. PubMed ID: 16387572
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Sexual function and dysfunction: from theory to practice].
    Ben ZI; Bronner G; Shtarkshall R
    Harefuah; 2009 Sep; 148(9):592-4, 658. PubMed ID: 20070047
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pharmacotherapy for erectile dysfunction.
    Eardley I; Donatucci C; Corbin J; El-Meliegy A; Hatzimouratidis K; McVary K; Munarriz R; Lee SW
    J Sex Med; 2010 Jan; 7(1 Pt 2):524-40. PubMed ID: 20092451
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Erectile dysfunction and renal chronic insufficiency: etiology and management].
    Phé V; Roupret M; Ferhi K; Barrou B; Cussenot O; Traxer O; Haab F; Beley S
    Prog Urol; 2009 Jan; 19(1):1-7. PubMed ID: 19135635
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Alleviation of post-radical prostatectomy cavernosal fibrosis: future directions and potential utility for PDE5 inhibitors.
    El-Sakka AI
    Expert Opin Investig Drugs; 2011 Oct; 20(10):1305-9. PubMed ID: 21846259
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The relationship between erectile dysfunction and cardiovascular disease. Part II: The role of PDE-5 inhibition in sexual dysfunction and cardiovascular disease.
    Kapur V; Chien CV; Fuess JE; Schwarz ER
    Rev Cardiovasc Med; 2008; 9(3):187-95. PubMed ID: 18953278
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Update of PDE5 inhibitors for the treatment of ischemia-reperfusion].
    Hu YY; Wu ZG
    Zhonghua Nan Ke Xue; 2011 Sep; 17(9):842-6. PubMed ID: 21961251
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The relationship between hypogonadism and erectile dysfunction.
    Hwang TI; Lin YC
    Int J Impot Res; 2008; 20(3):231-5. PubMed ID: 18305486
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Erectile dysfunction after radiotherapy for prostate cancer and radiation dose to the penile structures: a critical review.
    van der Wielen GJ; Mulhall JP; Incrocci L
    Radiother Oncol; 2007 Aug; 84(2):107-13. PubMed ID: 17707936
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Sexuality and prostate cancer].
    Droupy S; Al Said B; Lechevallier E; Colson MH; Giuliano F
    Prog Urol; 2013 Jul; 23(9):696-711. PubMed ID: 23830264
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Penile rehabilitation after radical prostatectomy.
    Briganti A; Montorsi F
    Nat Clin Pract Urol; 2006 Aug; 3(8):400-1. PubMed ID: 16902499
    [No Abstract]   [Full Text] [Related]  

  • 77. Treatment of erectile dysfunction and lower urinary tract symptoms by phosphodiesterase inhibitors.
    Uckert S; Stief CG
    Handb Exp Pharmacol; 2011; (204):307-22. PubMed ID: 21695646
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Oncologic and functional outcomes after radical prostatectomy in T3 prostate cancer].
    Xylinas E; Misraï V; Comperat E; Renard-Penna R; Vaessen C; Bitker MO; Chartier-Kastler E; Richard F; Cussenot O; Rouprêt M
    Prog Urol; 2009 May; 19(5):285-90. PubMed ID: 19393531
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Artery sparing radical prostatectomy--myth or reality?
    Mulhall JP; Secin FP; Guillonneau B
    J Urol; 2008 Mar; 179(3):827-31. PubMed ID: 18221962
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The role of vacuum erection devices in penile rehabilitation after radical prostatectomy.
    Lehrfeld T; Lee DI
    Int J Impot Res; 2009; 21(3):158-64. PubMed ID: 19225465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.